• Ananda Developments announces breakthrough in cardiac study with MRX1

  • Jun 26 2024
  • Duración: 4 m
  • Podcast

Ananda Developments announces breakthrough in cardiac study with MRX1 Por arte de portada

Ananda Developments announces breakthrough in cardiac study with MRX1

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Ananda Developments finance director Jeremy Sturgess-Smith shares promising results from preclinical studies investigating the efficacy of MRX1 in treating cardiac fibrosis and heart failure with preserved ejection fraction (HFpEF). Sturgess-Smith explained that Ananda Developments acquired MRX Medical, the company that owns the MRX1 IP, last year. The company specialises in chronic inflammatory pain conditions and cannabis-based medicinal treatments. The study shows that dosing MRX1 in mice with heart failure and preserved ejection fraction can bring heart and lung weight back to healthy levels and significantly reduce heart failure compounds. Sturgess-Smith emphasised the high unmet medical need in treating heart failure, with limited options beyond diet and exercise. Ananda Developments aims to include MRX1 as part of its treatment portfolio, alongside its existing two Phase II trials investigating Chemotherapy Induced Peripheral Neuropathy and Endometriosis. Next steps involve consultations with Dr Nadine Godsman, who led the trial, to determine whether to proceed with human studies or further mice data collection. Visit Proactive's YouTube channel for more videos, and don't forget to like, subscribe, and enable notifications for future content. #AnandaDevelopments #CardiacFibrosis #HeartFailureResearch #CannabisMedicine #MSCsMedical #ClinicalTrials #ProactiveInvestors #MedicalBreakthrough #HealthInnovation #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Más Menos
activate_primeday_promo_in_buybox_DT
Empresas y Profesiones Economía Finanzas Personales Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Ananda Developments announces breakthrough in cardiac study with MRX1

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles